MyMD Pharmaceuticals (MYMD) Competitors $1.27 -0.02 (-1.55%) (As of 12/24/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MYMD vs. TXMD, WENA, AWH, AIM, BCLI, JAGX, IPA, IMNN, RLMD, and CLRBShould you be buying MyMD Pharmaceuticals stock or one of its competitors? The main competitors of MyMD Pharmaceuticals include TherapeuticsMD (TXMD), ANEW Medical (WENA), Aspira Women's Health (AWH), AIM ImmunoTech (AIM), Brainstorm Cell Therapeutics (BCLI), Jaguar Health (JAGX), ImmunoPrecise Antibodies (IPA), Imunon (IMNN), Relmada Therapeutics (RLMD), and Cellectar Biosciences (CLRB). These companies are all part of the "pharmaceutical products" industry. MyMD Pharmaceuticals vs. TherapeuticsMD ANEW Medical Aspira Women's Health AIM ImmunoTech Brainstorm Cell Therapeutics Jaguar Health ImmunoPrecise Antibodies Imunon Relmada Therapeutics Cellectar Biosciences TherapeuticsMD (NASDAQ:TXMD) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership. Which has stronger earnings and valuation, TXMD or MYMD? MyMD Pharmaceuticals has lower revenue, but higher earnings than TherapeuticsMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTherapeuticsMD$1.60M8.02-$10.28MN/AN/AMyMD PharmaceuticalsN/AN/A-$4MN/AN/A Do institutionals and insiders hold more shares of TXMD or MYMD? 30.7% of TherapeuticsMD shares are owned by institutional investors. Comparatively, 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. 2.3% of TherapeuticsMD shares are owned by insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer TXMD or MYMD? In the previous week, TherapeuticsMD had 1 more articles in the media than MyMD Pharmaceuticals. MarketBeat recorded 1 mentions for TherapeuticsMD and 0 mentions for MyMD Pharmaceuticals. TherapeuticsMD's average media sentiment score of 0.00 equaled MyMD Pharmaceuticals'average media sentiment score. Company Overall Sentiment TherapeuticsMD Neutral MyMD Pharmaceuticals Neutral Does the MarketBeat Community favor TXMD or MYMD? TherapeuticsMD received 386 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTherapeuticsMDOutperform Votes38658.93% Underperform Votes26941.07% MyMD PharmaceuticalsN/AN/A Is TXMD or MYMD more profitable? MyMD Pharmaceuticals has a net margin of 0.00% compared to TherapeuticsMD's net margin of -207.77%. TherapeuticsMD's return on equity of -14.08% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TherapeuticsMD-207.77% -14.08% -9.61% MyMD Pharmaceuticals N/A -179.05%-108.14% Which has more risk and volatility, TXMD or MYMD? TherapeuticsMD has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. SummaryTherapeuticsMD beats MyMD Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Ad DTIWill the Nasdaq 100 crash?In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!Click here to get the details. Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYMD vs. The Competition Export to ExcelMetricMyMD PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.01M$2.53B$5.23B$9.28BDividend YieldN/A0.76%5.12%4.28%P/E RatioN/A6.1287.6917.27Price / SalesN/A77.201,168.45119.91Price / CashN/A15.1043.2337.82Price / Book0.183.344.834.94Net Income-$4M$29.98M$120.76M$225.76M7 Day Performance-12.41%0.61%2.49%3.92%1 Month Performance-9.29%6.56%17.55%1.71%1 Year Performance-82.19%-21.48%28.51%15.79% MyMD Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYMDMyMD PharmaceuticalsN/A$1.27-1.6%N/A-82.0%$3.01MN/A0.009Gap UpTXMDTherapeuticsMD0.4632 of 5 stars$1.10-0.9%N/A-51.9%$12.69M$1.60M0.00420High Trading VolumeWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpAWHAspira Women's Health1.2435 of 5 stars$0.75-2.8%$4.40+487.7%-73.3%$12.48M$8.96M-0.62110Analyst ForecastAIMAIM ImmunoTech2.2435 of 5 stars$0.19-1.3%$2.75+1,365.9%-59.8%$11.97M$190,000.00-0.4020BCLIBrainstorm Cell Therapeutics4.128 of 5 stars$2.07-9.2%$30.00+1,349.3%-24.8%$11.81MN/A-0.4340JAGXJaguar Health0.1191 of 5 stars$0.98+5.5%N/A-89.7%$11.52M$10.48M0.0050Gap UpIPAImmunoPrecise Antibodies2.5899 of 5 stars$0.40-0.3%$5.00+1,153.1%-70.0%$11.50M$24.07M-0.5180Upcoming EarningsGap UpIMNNImunon2.4112 of 5 stars$0.79-4.7%$20.50+2,492.6%+9.5%$11.47M$500,000.00-0.4233Gap DownRLMDRelmada Therapeutics4.3141 of 5 stars$0.38+4.6%$4.25+1,019.6%-88.2%$11.45MN/A-0.1310Gap DownCLRBCellectar Biosciences1.8014 of 5 stars$0.28+17.3%$17.67+6,307.9%-90.2%$11.38MN/A-0.1610Gap DownHigh Trading Volume Related Companies and Tools Related Companies TXMD Alternatives WENA Alternatives AWH Alternatives AIM Alternatives BCLI Alternatives JAGX Alternatives IPA Alternatives IMNN Alternatives RLMD Alternatives CLRB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MYMD) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
